Literature DB >> 16390984

Safe Mycobacterium tuberculosis DNA extraction method that does not compromise integrity.

Robin Warren1, Marianna de Kock, Erica Engelke, Roseline Myburgh, Nico Gey van Pittius, Thomas Victor, Paul van Helden.   

Abstract

Concern has been raised about the efficacy of the heat killing of mycobacteria during the isolation of DNA. We demonstrate a method that allows for the efficient killing of Mycobacterium tuberculosis without compromising DNA integrity for subsequent molecular investigation. This method reduces the risk of infection to the research scientist.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16390984      PMCID： PMC1351970          DOI： 10.1128/JCM.44.1.254-256.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

Review 1.  Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains.

Authors:  Pablo J Bifani; Barun Mathema; Natalia E Kurepina; Barry N Kreiswirth
Journal:  Trends Microbiol       Date:  2002-01       Impact factor: 17.079

2.  Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype.

Authors:  Thomas C Victor; Petra E W de Haas; Annemarie M Jordaan; Gian D van der Spuy; Madalene Richardson; D van Soolingen; Paul D van Helden; Robin Warren
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  The efficacy of the heat killing of Mycobacterium tuberculosis.

Authors:  C Doig; A L Seagar; B Watt; K J Forbes
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

4.  Extraction of Mycobacterium tuberculosis DNA: a question of containment.

Authors:  Wendy Somerville; Louise Thibert; Kevin Schwartzman; Marcel A Behr
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Inactivation of Mycobacterium tuberculosis for DNA typing analysis.

Authors:  P Bemer-Melchior; H B Drugeon
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

7.  Molecular evolution of Mycobacterium tuberculosis: phylogenetic reconstruction of clonal expansion.

Authors:  R M Warren; M Richardson; S L Sampson; G D van der Spuy; W Bourn; J H Hauman; H Heersma; W Hide; N Beyers; P D van Helden
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

8.  RIDOM: comprehensive and public sequence database for identification of Mycobacterium species.

Authors:  Dag Harmsen; Stefan Dostal; Andreas Roth; Stefan Niemann; Jörg Rothgänger; Michael Sammeth; Jürgen Albert; Matthias Frosch; Elvira Richter
Journal:  BMC Infect Dis       Date:  2003-11-11       Impact factor: 3.090
  8 in total
  22 in total

1.  Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa.

Authors:  E M Streicher; S L Sampson; K Dheda; T Dolby; J A Simpson; T C Victor; N C Gey van Pittius; P D van Helden; R M Warren
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

2.  Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis.

Authors:  Grant Theron; Jason Limberis; Rouxjeane Venter; Liezel Smith; Elize Pietersen; Aliasgar Esmail; Greg Calligaro; Julian Te Riele; Marianna de Kock; Paul van Helden; Tawanda Gumbo; Taane G Clark; Kevin Fennelly; Robin Warren; Keertan Dheda
Journal:  Nat Med       Date:  2020-06-29       Impact factor: 53.440

3.  Variants in Bedaquiline-Candidate-Resistance Genes: Prevalence in Bedaquiline-Naive Patients, Effect on MIC, and Association with Mycobacterium tuberculosis Lineage.

Authors:  Emmanuel Rivière; Lennert Verboven; Anzaan Dippenaar; Sander Goossens; Elise De Vos; Elizabeth Streicher; Bart Cuypers; Kris Laukens; Fathia Ben-Rached; Timothy C Rodwell; Arnab Pain; Robin M Warren; Tim H Heupink; Annelies Van Rie
Journal:  Antimicrob Agents Chemother       Date:  2022-06-27       Impact factor: 5.938

4.  Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex.

Authors:  K G P Hoek; N C Gey van Pittius; H Moolman-Smook; K Carelse-Tofa; A Jordaan; G D van der Spuy; E Streicher; T C Victor; P D van Helden; R M Warren
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

5.  Discordance between mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing and IS6110 restriction fragment length polymorphism genotyping for analysis of Mycobacterium tuberculosis Beijing strains in a setting of high incidence of tuberculosis.

Authors:  M Hanekom; G D van der Spuy; N C Gey van Pittius; C R E McEvoy; K G P Hoek; S L Ndabambi; A M Jordaan; T C Victor; P D van Helden; R M Warren
Journal:  J Clin Microbiol       Date:  2008-08-20       Impact factor: 5.948

6.  Melting the eis: Nondetection of Kanamycin Resistance Markers by Routine Diagnostic Tests and Identification of New eis Promoter Variants.

Authors:  Serej D Ley; Samantha Pillay; Elizabeth M Streicher; Yuri F van der Heijden; Frederik Sirgel; Brigitta Derendinger; Marianna de Kock; Sébastien Gagneux; Robin M Warren; Grant Theron; Margaretha de Vos
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

7.  Mycobacterium tuberculosis is the causative agent of tuberculosis in the southern ecological zones of Cameroon, as shown by genetic analysis.

Authors:  Jean Paul Assam Assam; Véronique Penlap Beng; Fidelis Cho-Ngwa; Michel Toukam; Ane-Anyangwe Irene Ngoh; Mercy Kitavi; Inoster Nzuki; Juliette N Nyonka; Emilienne Tata; Jean Claude Tedom; Robert A Skilton; Roger Pelle; Vincent P K Titanji
Journal:  BMC Infect Dis       Date:  2013-09-13       Impact factor: 3.090

8.  Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa.

Authors:  Marisa Klopper; Robin Mark Warren; Cindy Hayes; Nicolaas Claudius Gey van Pittius; Elizabeth Maria Streicher; Borna Müller; Frederick Adriaan Sirgel; Mamisa Chabula-Nxiweni; Ebrahim Hoosain; Gerrit Coetzee; Paul David van Helden; Thomas Calldo Victor; André Phillip Trollip
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

9.  Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.

Authors:  Karen Shean; Elizabeth Streicher; Elize Pieterson; Greg Symons; Richard van Zyl Smit; Grant Theron; Rannakoe Lehloenya; Xavier Padanilam; Paul Wilcox; Tommie C Victor; Paul van Helden; Martin P Grobusch; Martin Groubusch; Robin Warren; Motasim Badri; Keertan Dheda
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

10.  Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates.

Authors:  P A Black; M de Vos; G E Louw; R G van der Merwe; A Dippenaar; E M Streicher; A M Abdallah; S L Sampson; T C Victor; T Dolby; J A Simpson; P D van Helden; R M Warren; A Pain
Journal:  BMC Genomics       Date:  2015-10-24       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.